From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry
Variablesa | All implants (n = 178) |
---|---|
Valve size implanted, n (%) | Â |
 19 mm | 31 (17.4) |
 21 mm | 58 (32.6) |
 23 mm | 58 (32.6) |
 25 mm | 24 (13.5) |
 27 mm | 7 (3.9) |
Operative data | Â |
 Isolated AVR, n (%) | 81 (45.5) |
 CABG, n (%) | 63 (35.4) |
 ACC time, min | 67.9 ± 41.4 (45-95) |
 CPB time, min | 103.9 ± 45.7 (70-131) |
Postoperative data | Â |
 IABP, n (%) | 6 (3.4) |
 Re-exploration for bleeding, n (%) | 7 (3.9) |
 Stroke, n (%) | 2 (1.1) |
 Respiratory failure, n (%) | 14 (7.9) |
 Acute kidney injury, n (%) | 24 (13.5) |
 Renal replacement therapy, n (%) | 11 (6.2) |
 Atrial fibrillation, n (%) | 79 (44.4) |
 Ventilation, hours | 33.8 ± 98.8 (7-24) |
 ICU stay, hours | 68.5 ± 119.2 (24-60) |
 Hospital mortality, n (%) | 5 (2.8) |